RX IMOLA— 510(k) K052914

Substantially Equivalent

Randox Laboratories, Ltd.

FDA 510(k) clearance K052914 for RX IMOLA, Substantially Equivalent on 2006-03-31. Applicant: Randox Laboratories, Ltd..

Clearance details

Applicant: Randox Laboratories, Ltd.
Product code: Code CEM
Advisory panel: Clinical Chemistry
Date received: 2005-10-14
Decision date: 2006-03-31
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Crumlin, GB

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.